Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Federal Trade Commission
US Army
Chinese Patent Office

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for Patent: 8,697,125

« Back to Dashboard

Which drugs does patent 8,697,125 protect, and when does it expire?

Patent 8,697,125 protects NESINA and is included in one NDA. There has been one Paragraph IV challenge on Nesina.

This patent has eleven patent family members in ten countries.

Summary for Patent: 8,697,125

Title:Tablet preparation without causing a tableting trouble
Abstract: The present invention provides a tablet without causing a tableting trouble, which is superior in the tablet formability, dissolution property of pharmaceutically active ingredient, and the like.
Inventor(s): Ono; Akihiko (Osaka, JP), Marunaka; Shigeyuki (Osaka, JP), Fukuta; Makoto (Osaka, JP)
Assignee: Takeda Pharmaceutical Company Limited (Osaka, JP)
Application Number:12/449,256
Patent Claim Types:
see list of patent claims
Compound; Dosage form; Formulation; Use;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Takeda Pharms UsaNESINAalogliptin benzoateTABLET;ORAL022271-001Jan 25, 2013RXYesNo► Subscribe► Subscribe► SubscribeY
Takeda Pharms UsaNESINAalogliptin benzoateTABLET;ORAL022271-002Jan 25, 2013RXYesNo► Subscribe► Subscribe► SubscribeY
Takeda Pharms UsaNESINAalogliptin benzoateTABLET;ORAL022271-003Jan 25, 2013RXYesYes► Subscribe► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 8,697,125

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan2007-023584Feb 1, 2007
PCT Information
PCT FiledJanuary 30, 2008PCT Application Number:PCT/JP2008/051896
PCT Publication Date:August 07, 2008PCT Publication Number: WO2008/093878

International Patent Family for Patent: 8,697,125

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Japan2010517936► Subscribe
CroatiaP20171518► Subscribe
Spain2639854► Subscribe
European Patent Office2124901► Subscribe
Chile2008000280► Subscribe
Canada2677193► Subscribe
Argentina065096► Subscribe
Japan5284967► Subscribe
Peru17342008► Subscribe
Taiwan200836774► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: